Bisphosphonate Therapy for Osteoporosis: New Guidelines

Iåçf you’re at high risk for fractures, you can continue BP therapy for up to 10 years (oral) or up to six years (intravenous). with clinician monitoring.

Bisphosphonates (BP) were initially developed in the 1960s, but their use in arresting bone loss began in the 1990s. They are the most commonly used medication for osteoporosis—in the U.S. alone, osteoporosis results in 1.5 million fractures per year. Alendronate (Fosamax) was the first BP drug commercially available to treat osteoporosis. Reassessing risks/benefits New findings […]

Comments

Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×